Skip to main content
. 2017 Aug 7;23(29):5304–5312. doi: 10.3748/wjg.v23.i29.5304

Figure 2.

Figure 2

Presentation of celecoxib-induced liver lesions at 48 h. Controls presented with pronounced microvesicullar and macrovesicullar steatosis, dilated sinusoids, and piecemeal necrosis (A); BPC 157 rats presenting with minimal microvesicullar steatosis and no necrosis (B). HE × 40.